The serotonin-N-acetylserotonin–melatonin pathway as a biomarker for autism spectrum disorders

por Pagan, C, Delorme, R, Callebert, J, Goubran-Botros, H, Amsellem, F, Drouot, X, Boudebesse, C, Le Dudal, K, Ngo-Nguyen, N, Laouamri, H, Gillberg, C, Leboyer, M, Bourgeron, T, Launay, J-M
Publicado 2014

CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders

por Mercati, O, Huguet, G, Danckaert, A, André-Leroux, G, Maruani, A, Bellinzoni, M, Rolland, T, Gouder, L, Mathieu, A, Buratti, J, Amsellem, F, Benabou, M, Van-Gils, J, Beggiato, A, Konyukh, M, Bourgeois, J-P, Gazzellone, M J, Yuen, R K C, Walker, S, Delépine, M, Boland, A, Régnault, B, Francois, M, Van Den Abbeele, T, Mosca-Boidron, A L, Faivre, L, Shimoda, Y, Watanabe, K, Bonneau, D, Rastam, M, Leboyer, M, Scherer, S W, Gillberg, C, Delorme, R, Cloëz-Tayarani, I, Bourgeron, T
Publicado 2017